Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...
For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's also beneficial because the HIV virus is always evolving.
A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...
People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...
Frimpong’s invited commentary discusses the significance of a major efficacy trial involving the game Tumaini and what it ...
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results